Publications

Sorted from newest to oldest

  • Levine JA, Oleaga C, Eren M, Amaral AP, Shang M, Lux E, Khan SS, Shah SJ, Omura Y, Pamir N, Hay J, Barish G, Miyata T, Tavori H, Fazio S, Vaughan DE. Role of PAI-1 in hepatic steatosis and dyslipidemia. Sci Rep. 2021 Jan 11;11(1):430. doi: 10.1038/s41598-020-79948-x. PubMed PMID: 33432099; PubMed Central PMCID: PMC7801442.
  • Pamir N, Fazio S. Lipoprotein(a) Gets Worse. Circ Res. 2020 May 8;126(10):1360-1362. doi: 10.1161/CIRCRESAHA.120.316980. Epub 2020 May 7. PubMed PMID: 32379575; PubMed Central PMCID: PMC7252907.
  • Pamir N, Hutchins PM, Ronsein GE, Wei H, Tang C, Das R, Vaisar T, Plow E, Schuster V, Koschinsky ML, Reardon CA, Weinberg R, Dichek DA, Marcovina S, Getz GS, Heinecke JW. Plasminogen promotes cholesterol efflux by the ABCA1 pathway. JCI Insight. 2017 Aug 3;2(15). doi: 10.1172/jci.insight.92176. eCollection 2017 Aug 3. PubMed PMID: 28768900; PubMed Central PMCID: PMC5543924.
  • Tavori H, Christian D, Minnier J, Plubell D, Shapiro MD, Yeang C, Giunzioni I, Croyal M, Duell PB, Lambert G, Tsimikas S, Fazio S. PCSK9 Association With Lipoprotein(a). Circ Res. 2016 Jun 24;119(1):29-35. doi: 10.1161/CIRCRESAHA.116.308811. Epub 2016 Apr 27. PubMed PMID: 27121620; PubMed Central PMCID: PMC4920709.
  • Giunzioni I, Tavori H, Covarrubias R, Major AS, Ding L, Zhang Y, DeVay RM, Hong L, Fan D, Predazzi IM, Rashid S, Linton MF, Fazio S. Local effects of human PCSK9 on the atherosclerotic lesion. J Pathol. 2016 Jan;238(1):52-62. doi: 10.1002/path.4630. Epub 2015 Nov 13. PubMed PMID: 26333678; PubMed Central PMCID: PMC5346023.